Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. - Wikidata - awgldk - TriplyDB

Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction.

Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction.

http://www.wikidata.org/entity/Q44762713

about

Morphological and glucose metabolism abnormalities in alcoholic Korsakoff's syndrome: group comparisons and individual analyses Hybrid PET/MR Imaging and Brain Connectivity Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data A non-parametric approach for co-analysis of multi-modal brain imaging data: application to Alzheimer's disease Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease.Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease.Cerebral 5-HT2A receptor and serotonin transporter binding in humans are not affected by the val66met BDNF polymorphism status or blood BDNF levels.Familial risk for mood disorder and the personality risk factor, neuroticism, interact in their association with frontolimbic serotonin 2A receptor binding.Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia.Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.Binding in working memory and frontal lobe in normal aging: is there any similarity with autism?When structure affects function--the need for partial volume effect correction in functional and resting state magnetic resonance imaging studies.Putamen-midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseases.Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease Early-Phase 11C-PiB PET in Amyloid Angiopathy-Related Symptomatic Cerebral Hemorrhage: Potential Diagnostic Value?Preserved acetazolamide reactivity in lacunar patients with severe white-matter lesions: 15O-labeled gas and H2O positron emission tomography studies.Construction and comparative evaluation of different activity detection methods in brain FDG-PET.Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala.Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.Caudolateral orbitofrontal regional cerebral blood flow is decreased in abstinent cocaine-addicted subjects in two separate cohorts.Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography.Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations Correlation between resting state fMRI total neuronal activity and PET metabolism in healthy controls and patients with disorders of consciousness Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging Quantification of the novel N-methyl-d-aspartate receptor ligand [11C]GMOM in man MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes Practical method for radioactivity distribution analysis in small-animal PET cancer studies.A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer's disease.The feasibility of (11)C-PIB-PET/CT for amyloid plaque burden: validation of the effectiveness of CT-based partial volume correction.Imaging analysis of Parkinson's disease patients using SPECT and tractography Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis.Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising.Noise suppressed partial volume correction for cardiac SPECT/CT.Image coregistration: quantitative processing framework for the assessment of brain lesions.Region-Based Partial Volume Correction Techniques for PET Imaging: Sinogram Implementation and Robustness.Direct voxel-based comparisons between grey matter shrinkage and glucose hypometabolism in chronic alcoholism.

P2860

Q21142710-6B693100-5F0B-4F01-9340-8C38ED61C044 Q26766043-4A3915CF-249B-4F23-A05A-E44AFBA2C263 Q30722226-C1B597A5-74C6-48AB-8B94-0722F89F2E41 Q31029702-ABBDADDE-9382-4612-A9BE-210ABA999C51 Q33700069-02EE3E84-53A7-4C55-8DE1-583126DCEC6E Q33988394-EC4ED006-6A86-48C9-BD90-917F88162F37 Q34116029-03AB626F-F3C2-487C-9384-BDBE49AB67B5 Q34505000-9258D230-7C96-4126-A4CD-9EEE5752C0FC Q34660833-FA042679-35A4-4942-B824-4CFBDEB9A8EF Q34671684-5AF63098-A44C-47C5-BB8B-79B73C4BD58F Q34712689-0B462DDC-85E7-4B7F-B35A-6060F09F3E2A Q34793304-7A6D74BA-4516-42A7-914F-D652C862531C Q35184292-40DEC979-4E3D-4E7E-B69E-386A0A289D28 Q35474769-C70B639A-3E08-4096-802E-9E5325C05810 Q35794074-3776C7D8-E2F3-445D-BE9B-2EC1E6D0C1C0 Q35794275-4CDD19A4-8425-41E2-85BE-2AB93DE638D9 Q35800210-12F033F3-EC40-4AE3-8ACA-3B7D56BF275B Q35939199-E837A534-0F1F-4BD5-99C9-4BA1355FFA4C Q35964685-D3ACB28F-5AF4-45B0-A9E5-173836DFD4DD Q36165163-1F5F9E37-31B3-41D1-896A-F27A3AA1F6D4 Q36175217-8E96C046-CE72-45FA-82B4-1D3E5343AAAD Q36366484-E94B3C87-583D-47F3-941E-D9C26DE308C4 Q36508977-A423B3F4-FFB6-4F19-B167-0940196C44BD Q36675034-B4BD7FC7-33F4-4ED9-82F7-85E460C160A5 Q36795245-33348E11-4842-49A5-ACE4-EA126B80B15F Q36807684-1910F919-2D1C-4321-90BF-41155A54E8FF Q36854032-2183EB4E-7843-413B-9C9E-97AD3600A9AD Q36996488-D2911E3C-36F8-4F51-8034-76AAFC034D94 Q37082457-074C2F85-2DDB-4518-A6E6-C12B9B98F19D Q37100705-05F8C9BF-F5FD-42F3-A69D-CA2B5888CE55 Q37185341-884C4AD1-7794-4F23-A590-719889A364D7 Q37217103-D8EE38CE-A79A-4C5D-A531-15C4ADB92164 Q37339778-710F1D51-D64C-4C24-8C8C-B42A404D2A7A Q37454387-9A9FB73F-0955-4221-B285-205CF2306A59 Q37683109-84A4FA55-C1AF-4798-A981-E869F2053C50 Q38825502-D6CD40D9-A478-4A57-878C-5F7A1D48CDF6 Q39430044-1A4AC2C0-915C-4214-A252-450D66CB218A Q39751883-AD22DA6E-5EA8-4A96-8846-DBCEF3659A58 Q40166035-96867E3F-6D70-4A13-AC23-19A45E54E390 Q41022824-96F4A67A-7326-4C7B-815B-E2CBDA365539

P2860

Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction.

http://www.wikidata.org/entity/Q44762713

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Integrated software for the an ...... tial-volume-effect correction.

@en

Integrated software for the an ...... tial-volume-effect correction.

@nl

type

label

Integrated software for the an ...... tial-volume-effect correction.

@en

Integrated software for the an ...... tial-volume-effect correction.

@nl

prefLabel

Integrated software for the an ...... tial-volume-effect correction.

@en

Integrated software for the an ...... tial-volume-effect correction.

@nl

P1433

Q44762713-80B815AB-D41C-4613-8AFB-7C4F2B0871FB

P1476

Q44762713-13DD94F9-DF5F-469B-800F-538666398824

P2093

Q44762713-0A9DCF00-1ACB-4090-8316-DF2A03F9C5EA

Q44762713-3A7866CA-E324-4DA8-85B8-6E81397B37D6

Q44762713-41550E61-F238-46E8-BA71-9F1B20441B8B

Q44762713-57F5F942-1347-44E6-B10F-0B85CEC72A32

Q44762713-593FFAA0-FCED-47B0-BCC6-DEB232AE25AB

Q44762713-7E018905-660C-4EBD-BA3E-424D2CD8F468

Q44762713-9D356979-F051-490C-9D3F-6321A88A2713

Q44762713-C0BB4EB2-D685-40D9-AE71-27D82DDFB064

Q44762713-CF9F21AB-4880-4235-8AE3-4CAEDE117E46

P304

Q44762713-BD0784FE-38B6-42DC-8377-73C9E1E0859D

P31

Q44762713-2DF617A4-B9B9-4BE6-8817-D091CCD53D53

P407

Q44762713-A90E59FA-0709-4DA3-BAB1-C1DB566EAE9C

P433

Q44762713-79A2E61A-B948-4A69-8C48-EA55FFF02E3D

P478

Q44762713-822DA594-5849-4A1D-B349-0127AD15FA22

P50

Q44762713-B1089D72-256B-431B-9423-708720F4AB54

P577

Q44762713-4837BAB4-1C45-41BF-90C3-B70FFDC7A262

P698

Q44762713-99092ADD-891B-4E8D-99AD-E0A1C5D64CED

P1433

The Journal of Nuclear Medicine

P1476

Integrated software for the an ...... tial-volume-effect correction.

@en

P2093

Anna Prinster

http://www.w3.org/2001/XMLSchema#string

Arturo Brunetti

http://www.w3.org/2001/XMLSchema#string

Brigitte Landeau

http://www.w3.org/2001/XMLSchema#string

Bruno Alfano

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Baron

http://www.w3.org/2001/XMLSchema#string

Karim Berkouk

http://www.w3.org/2001/XMLSchema#string

Laszlo Balkay

http://www.w3.org/2001/XMLSchema#string

Marco Salvatore

http://www.w3.org/2001/XMLSchema#string

Mario Quarantelli

http://www.w3.org/2001/XMLSchema#string

P304

192-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14960635

http://www.w3.org/2001/XMLSchema#string